AARP’s new research finds price growth for top Part D prescription drugs has exceeded inflation, making a case for allowing ...

Findings show the impact of drug companies’ relentless price increases, underscoring the importance of the changes included ...

Novo Nordisk expects Ozempic, which has been on the market since 2017, will be on Medicare's list of drugs to negotiate prices concessions, Bloomberg reported. The company told USA TODAY that it would ...

Medicare’s drug pricing negotiations — the first of their kind in the United States, passed under President Joe Biden — face ...

Millions of Medicare enrollees are likely to see relief in 2025 when a $2,000 cap on out-of-pocket prescription drug-spending ...

are on 10 or more drugs. As a career geriatrician, I've seen it firsthand: One of the best ways to improve your personal health is to work with your doctors to edit down your prescription list.

Each plan’s drug list or “formulary” may differ. New coverage rules for 2025 have also eliminated out-of-pocket Part D prescription drug costs over $2,000 on covered medications, known as ...

SANTA FE — New Mexico's personal income tax structure will be retooled and prescription drug manufacturers will have to start disclosing pricing information to state regulators under laws set to take ...

Prescription medications are essential for managing many health conditions. However, it’s crucial to recognize that these ...

There are many prescription and over-the-counter medications available that can provide relief for muscle spasms and muscle spasticity. Muscle relaxers, or muscle relaxants, are medications used ...

Starting in 2025, over 850,000 Americans with Medicare will benefit from lower prescription drug costs as part of the Inflation Reduction Act.